Carrie Hinton
Family · Clarksville, TXNPI 1912914151
Payments from drug & device makers
Across 408 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$933
- AbbVie$910
- Alkermes, Inc.$820
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$699
- Vanda Pharmaceuticals Inc.$589
- plus $2K from 9 others
What the payments were for
- Food & beverage$6,626100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 41 | $1,101 |
| Otsuka America Pharmaceutical, Inc. | 48 | $933 |
| AbbVie | 118 | $910 |
| Alkermes, Inc. | 53 | $820 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 43 | $699 |
| Vanda Pharmaceuticals Inc. | 28 | $589 |
| Teva Pharmaceuticals USA, Inc. | 19 | $362 |
| Indivior Inc. | 16 | $339 |
| Johnson & Johnson | 10 | $307 |
| E.r. Squibb & Sons, L.L.C. | 16 | $285 |
| Sunovion Pharmaceuticals Inc. | 12 | $204 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Eisai Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,628 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 16 | $392 |
| Celecoxib | 12 | $115 |
| Hydrochlorothiazide | 14 | $39 |
| Simvastatin | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other family in Clarksville
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.